Published in J Neurochem on April 01, 1992
MPTP mouse models of Parkinson's disease: an update. J Parkinsons Dis (2011) 1.02
Functional properties of the uptake of amines in immortalised peptidergic neurones (transport-P). Br J Pharmacol (1996) 0.84
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39
Sympathetic cardioneuropathy in dysautonomias. N Engl J Med (1997) 3.14
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Synthesis of nitric oxide in CNS glial cells. Trends Neurosci (1993) 2.81
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol (1998) 2.47
Nerve growth factor, laminin, and fibronectin promote neurite growth in human fetal sensory ganglia cultures. J Neurosci Res (1982) 2.28
The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med (1977) 2.28
Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood (1992) 2.06
Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J Pharmacol Exp Ther (1968) 1.99
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
Cardiac sympathetic nerve function in congestive heart failure. Circulation (1996) 1.84
Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci (1998) 1.75
Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem (1989) 1.68
Proportional release of norepinephrine and dopamine- -hydroxylase from sympathetic nerves. Science (1971) 1.68
3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochem Pharmacol (1968) 1.64
Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology (1981) 1.59
Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings. Pharmacol Rev (1966) 1.58
Plasma noradrenaline increases with age. Nature (1976) 1.56
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev (1985) 1.53
False adrenergic transmitters. Annu Rev Pharmacol (1968) 1.50
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg (1990) 1.48
L-Dopa-induced release of cerebral monoamines. Science (1970) 1.47
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem (1993) 1.47
The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro. J Pharmacol Exp Ther (1967) 1.44
Detection of GPIV (CD36) mRNA in Naka- platelets. Thromb Haemost (1991) 1.41
Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest (1988) 1.41
The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. J Pharmacol Exp Ther (1968) 1.40
2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology (1990) 1.40
Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension (1983) 1.40
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience (1981) 1.40
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci (1986) 1.39
The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett (1997) 1.39
Medication errors with inhalant epinephrine mimicking an epidemic of neonatal sepsis. N Engl J Med (1984) 1.37
Enhanced release of dopamine- -hydroxylase from sympathetic nerves by calcium and phenoxybenzamine and its reversal by prostaglandins. Proc Natl Acad Sci U S A (1971) 1.37
Inhibition of release of dopamine- -hydroxylase and norepinephrine from sympathetic nerves by colchicine, vinblastine, or cytochalasin-B (hypogastric nerve stimulation-exocytosis-microtubules-microfilaments-guinea pig). Proc Natl Acad Sci U S A (1972) 1.36
Metabolism of tyramine-3H and octopamine-3H by rat brain. Biochem Pharmacol (1969) 1.35
Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci (1976) 1.33
Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am J Physiol (1998) 1.30
Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol (2010) 1.30
Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience (2003) 1.29
Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther (1966) 1.29
Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram. Am J Psychiatry (1977) 1.28
Elevation of adrenal tyrosine hydroxylase and phenylethanolamine-N-methyl transferase by repeated immobilization of rats. Endocrinology (1970) 1.27
Enhanced release of dopamine -hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3', 5'-monophosphate and theophylline. Mol Pharmacol (1973) 1.27
Stimulus-induced release of substances from olfactory bulb using the push-pull cannula. Nature (1968) 1.26
Effect of handling and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-beta-hydroxylase. Endocrinology (1978) 1.24
Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med (1977) 1.24
Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann N Y Acad Sci (1995) 1.23
On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs. Mol Pharmacol (1975) 1.23
Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli. Amino Acids (2006) 1.21
Letter: Sympathoadrenal medullary activity in young, spontaneously hypertensive rats. Nature (1975) 1.21
Plasma levels of norepinephrine. Ann Intern Med (1978) 1.20
Mechanism of release of norepinephrine from peripheral adrenergic neurones by the calcium ionophores X 537A and A 23187. Life Sci (1974) 1.19
A sensitive radioimmunoassay for 7S nerve growth factor antigens in serum and tissues. J Neurochem (1971) 1.19
NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem (2001) 1.16
Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci U S A (1983) 1.16
Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J Neurochem (1995) 1.16
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde. J Neurosci Res (2000) 1.16
Cyclic AMP-mediated induction of the cyclic AMP phosphodiesterase of C-6 glioma cells. Proc Natl Acad Sci U S A (1974) 1.15
Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci (1967) 1.15
Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front Neuroendocrinol (1995) 1.14
Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J Neurosci Res (1998) 1.14
The role of nerve growth factor in the ramification of sympathetic nerve fibres into the rat iris in organ culture. J Neurochem (1972) 1.13
Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology (1993) 1.13
A model of fulminant hepatic failure in the rabbit. Gastroenterology (1978) 1.12
Deficient sympathetic nervous response in familial dysautonomia. N Engl J Med (1976) 1.12
Defective specialized SP beta transducing bacteriophages of Bacillus subtilis that carry the sup-3 or sup-44 gene. J Bacteriol (1981) 1.12
Postoperative ileus in the rat: physiopathology, etiology and treatment. Ann Surg (1973) 1.11
Plasma catecholamine concentrations in unanesthetized rats during sleep, wakefulness, immobilization and after decapitation. J Pharmacol Exp Ther (1977) 1.10
Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest (1996) 1.09
Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science (1989) 1.09
Electrical field-stimulated release of norepinephrine-H3 from rat atrium: effects of ions and drugs. J Pharmacol Exp Ther (1969) 1.09
Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J Biol Chem (1998) 1.09
Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man. Science (1970) 1.08
Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J Neurosci Res (1998) 1.08
Norepinephrine metabolism in hypertrophied rat hearts. Nature (1965) 1.07
Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res (1975) 1.07
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res (2000) 1.07
Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. Biomed Mass Spectrom (1981) 1.06
Altered nerve growth factor in fibroblasts from patients with familial dysautonomia. Proc Natl Acad Sci U S A (1980) 1.05
Central GABAergic innervation of neurointermediate pituitary lobe: biochemical and immunocytochemical study in the rat. Proc Natl Acad Sci U S A (1982) 1.05
Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J Neurochem (1997) 1.05
Simultaneous assay by mass fragmentography of vanillyl mandelic acid, homovanillic acid, and 3-methoxy-4-hydroxy-phenethylene glycol in cerebrospinal fluid and urine. Biochem Med (1974) 1.05
Elevation of serum dopamine-beta-hydroxylase activity with forced immobilization. Nat New Biol (1971) 1.05
Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res (1995) 1.05
Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum. Neuroscience (1981) 1.04
Influence of sodium and calcium on norepinephrine uptake by isolated perfused rat hearts. Am J Physiol (1968) 1.04
Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab (1995) 1.03
Effect of ions on stimulus-induced release of amino acids from mammalian brain slices. J Neurochem (1969) 1.03
The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves. Prog Brain Res (1969) 1.03
Differential inhibiton of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses in pithed rats. J Pharmacol Exp Ther (1980) 1.01
Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry (1988) 1.01
Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation (1990) 1.01
Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol (1989) 1.01
Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats. J Pharmacol Exp Ther (1979) 1.00
Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependence. Pharmacogenomics J (2007) 1.00
Subcellular distribution and release by sympathetic nerve stimulation of dopamine and alpha-methyl dopamine. J Pharmacol Exp Ther (1966) 1.00